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There now appears to be agreement among researchers involved in studying the 
electrospray mechanism that small molecules enter the gas phase by IEM and large 






























































       
 
 +TOF MS: Period 2, Experiment 1, 8.762 to 8.940 min from BSA_STDCHECKMAR141-01298.... Max. 1.4e4 counts.
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4 0 0 0 0 6 0 0 0 0 8 0 0 0 0 1 0 0 0 0 0 1 2 0 0 0 0 1 4 0 0 0 0
m /z
ESI MALDI +1 MH+ = 66425 A B 
+2 
m/z = 1108.1 
(+60 H+) m/z = 3322.3 
(+20 H+) (2M + H)+ 
 
 







Mass reconstruction of  +TOF MS: Period 2, Experiment 1, 8.727 to 9.011 min from BSA_STDCHE... Max. 1.1e5 cps.





























































65500 66000 66500 67000 67500 68000
m/z
Molecular ion region of MALDI spectrum 
m/z 132,738 m/z 33,200
Deconvoluted ESI mass spectrum
D C 
MH+ = 66431
MH+ = 66432PW = 18 Da 


















































































































































































Angiotensin I  DRVYIHPFHL  1295.6774  7.9  0.2  ‐0.5  Neutral 
Angiotensin II  DRVYIHPF  1045.5345  7.8  0.1  ‐0.3  Neutral 
Angiotensin 
III 
RVYIHPF  930.5075  9.8  1.1  ‐0.8  Basic 
Renin 
substrate 







































































































































500  50 4881 4898  502
750  100 3254 3265  753
1000  150 2441 2449  1004
1500  250 1627 1633  1506































































































































charge 3.0 2.0 1.0
ions (m/z) 349.5 523.7 1046.3 sum
#1 552 619249 100125 719926
#2 668 570707 92621 663996
#3 290 600852 95507 696649
#4 840 637589 103636 742065
avg. 587.6 607099.3 97972.3 705659.1
sd 230.9 28522.9 4879.4 33396.3
%CV 27.5 4.5 4.7 4.5
RS  
charge 4.0 3.0 2.0 1.0 (RS+2Na+)/3 (RS+Na+)/2
ions (m/z) 440.6 587 880 1758.6 594.3 890.9
#1 3040 365865 262384 9704 54020 152950
#2 3050 326770 244742 8822 48638 143816
#3 2780 335930 263873 9440 54020 150431
#4 3220 365250 273555 9855 47911 160768
avg. 3022.5 348453.8 261138.5 9455.3 51147.3 151991.3
sd 181.5 20102.2 12000.6 455.8 3330.4 7005.2
%CV 5.6 5.5 4.4 4.6 7.0 4.4
CHCA
charge 1 1 1
ions (m/z) 172.1 190 207 212
#1 43756 3300 2020 3199
#2 36578 2860 2107 3309
#3 41500 3000 1820 3400
#4 39893 3075 2000 3555
avg. 40431.8 3058.8 1986.8 3365.6
sd 3018.5 183.9 120.5 150.6



















 (CHCA RS CHCA RS H )− +⎯⎯→+ +←⎯ +
)
 (2-3) 
 3 3( ) (CH OH H RS CH OH RS H
+ +⎯⎯→+ + + +←⎯  (2-4) 






















Basic  pKa Acidic pKa 
N‐terminus (amino)  9.69  C‐terminus    (carboxylic acid)  2.34 
lysine (amino)  10.5  aspartic acid  (carboxylic acid)  3.86 
arginine (guanidino)  12.4  glutamic acid  (carboxylic acid)  4.25 
histidine (imidazole)  6.00  tyrosine           (phenol)  8.33 






















































AngII has six fewer amino acid residues, but more important for this study, two 
fewer basic sites than RS, therefore lower charge states are predicted in the theoretical 
calculations.  The predicted predominant charge state at pH 2.5 is predicted to be +4 





















pH          2             4            6            8             10           12         14 



























]+ −=  (2-5) 
 
2 0ax bx c+ + =  (2-6) 
 






− ± −=  (2-8) 
 

















sample   uM peptide H+ / peptide ratio calc. M/A 
M/A 500  98 113 510.2 
M/A 750  65 171 769.2 
M/A 1000  49 226 1020.4 
M/A 1500  33 336 1515.2 































































































































M = 49 mM CHCA 










































M = 49 mM CHCA 























































































































































































































































































































































































500  0  0.0  80848  71.6  27280  24.1  4850  4.3  112978
750  0  0.0  86189  73.2  26300  22.3  5197  4.4  117686
1000  0  0.0  74250  75.8  20320  20.7  3439  3.5  98009
1500  3600  4.2  65091  76.4  14434  16.9  2050  2.4  85175





























































































Ang I, II, III
























Ang. III  +1
Ang. II  +1
Ang. I  +1
Ang. I  +2
Ang. II  +2
Ang. III  +2
Ang. I  +3
Ang. II  +3






















































































































































                      

















































































































    2 ( 2 )M H O M H O
+ + ⎯⎯→ +g +g
2







 2( ) ( )M H M H O H O















 2( 2 ) ( )M Na M Na Na+ ++ ⎯⎯→ + + +  (2-15) 
 

























































































































































































































































































































































































































Peptide  Sequence MW (Da) Isoelectric point† 
Angiotensin II  DRVYIHPF  1046.18  7.5 




















































Peptide Intermediate Solution 500  0  11959  11921 
Peptide Intermediate Solution 750  40  6644  6623 
Peptide Intermediate Solution 1000  71  4942  4926 
Peptide Intermediate Solution 1500  120  3517  3506 

















Peptide Intermediate Solution 500  0  5200  5199 
Peptide Intermediate Solution 1500  47  2680  2680 
Peptide Intermediate Solution 2000  71  2149  2148 















Peptide  MW mono pKa Peptide sequence uM
Allantoin  158.0440  189.8 
RASG‐1  1000.4938  9.34  RGDSPASSKP  30.0 
Angiotensin frag. 1‐7  898.4661  7.35  DRVYIHP  33.4 
Bradykinin  1059.5613  12.00  RPPGFSPFR  28.3 
Angiotensin II  1045.5345  7.35  DRVYIHPF  28.7 
Angiotensin I  1295.6775  7.51  DRVYIHPFHL  23.2 
Renin substrate  1757.9253  7.61  DRVYIHPFFHLLVYS  17.1 
Enolase T35  1871.9604  7.34  WLTGPQLADLYHSLMK  16.0 
Enolase T37  2827.2806  3.97  YPIVSIEDPFAEDDWEAWSHFFK  10.6 











































































































































































































Fast evap. B.A.Dried droplet 
            




































































































Inner region of higher sample coverage 
Droplet sizes gradually decrease toward 
the outer edge of spray 
























































Fast evaporation/Thin layerB.Dried droplet A. 
Methanol/Water (67:33) Methanol/Water (98:2) 












































Ang II MH+ 
Dried droplet 
Brady MH+ 
alkali adduct peaks 
Fast evaporation 
Ang II MH+ 
Ang II MNa+ 
Brady MNa+ 

















































































A M/A 750 B M/A 500 
 
m/z that is imaged 
D M/A 1000 C M/A 1500
 













M/A 750 BA M/A 500 Bradykinin MH+ 
    
C DM/A 1000 M/A 1500









































































































M/A1000 A M/A 1500 B
 
















































A Ang. II Bradykinin B 
 
































































Ang.II MH+ Brady MH+ A. B.
m/z 1046.5  m/z 1060.5 
   
Brady MH+ C. Ang.II MH+ D.
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i j pKapKapH pH
i j





























































































































Peptide 1  VLAGVFAGKK  988.6070  2  10.4  ‐0.2  0.20  17.9 
Peptide 2  VLAGVFAGKK‐NH2  987.6229  3  10.4  ‐0.2  0.20  18.7 
Peptide 3  Ac‐VLAGVFAGKK‐NH2 1029.6335  2  10.4  ‐0.2  0.20  25.6 
Peptide 4  Ac‐KKVLAGVFAG‐NH2 1029.6335  2  10.4  ‐0.2  0.20  25.6 
Peptide 5  Ac‐KVLASKVFAG‐NH2  1059.6441  2  10.4  ‐0.2  0.30  25.6 
Peptide 6  Ac‐KVFAGVFAGK‐NH2  1063.6179  2  10.4  ‐0.3  0.20  25.6 
Peptide 7  Ac‐VFAGKKVLAS‐NH2  1059.6441  2  10.4  ‐0.2  0.30  25.6 
Peptide 8  Ac‐ VFASKVLASK ‐NH2 1089.6546  2  10.4  ‐0.2  0.40  25.6 










































































































































































Peptide 1  VLAGVFAGKK  97.0 %  989.6  989.6 
Peptide 2  VLAGVFAGKK‐NH2  99.3 %  988.6  988.6 
Peptide 3  Ac‐VLAGVFAGKK‐NH2  99.1 %  1030.6  1030.6 
Peptide 4  Ac‐KKVLAGVFAG‐NH2  99.7 %  1030.6  1030.6 
Peptide 5  Ac‐KVLASKVFAG‐NH2  98.5 %  1060.6  1060.6 
Peptide 6  Ac‐KVFAGVFAGK‐NH2  98.2 %  1064.6  1064.6 
Peptide 7  Ac‐VFAGKKVLAS‐NH2  99.0 %  1060.6  1060.6 
Peptide 8  Ac‐ VFASKVLASK ‐NH2  98.5 %  1090.7  1090.6 


















































QTI  Theoretical % N Experimental % N Peptide Content
Peptide 7 17.17 9.90 57.7
Peptide 8 16.70 10.81 64.7
Genscript Theoretical % N Experimental % N Peptide Content
Peptide 1 16.99 12.15 71.5
Peptide 2 18.43 12.90 70.0
Peptide 3 17.67 13.22 74.8
Peptide 4 17.67 12.83 72.6
Peptide 5 17.17 10.44 60.8
Peptide 6 17.11 12.94 75.6
Peptide 7 17.17 9.77 56.9
Peptide 8 16.70 11.33 67.8

























*DAD1, 6.473 : 6.523 (939 mAU,%Fs) Ref=6.363 & 6.850 of 003-0301.D


















































































































UV 205 nm Peptide 1 Peptide 2 Peptide 3 Peptide 4 Peptide 5 Peptide 6 Peptide 7 Peptide 8 Peptide 9
1 6312 10910 7158 5830 6247 4754 3461 4344 3312
2 6570 11003 7216 5865 6208 4728 3402 4363 3316
3 6200 11221 7160 5819 6199 4800 3551 4341 3365
avg. 6360 11044 7178 5838 6218 4761 3471 4349 3331
stdev. 189.6 159.6 32.7 24.1 25.6 36.8 75.0 11.7 29.9
% RSD 2.98 1.44 0.46 0.41 0.41 0.77 2.16 0.27 0.90



















P Pro 2675 Peptide Sequence
Predicted Molar 
Extinction Coefficient
H His 5125 1 VLAGVFAGKK 13826
F Phe 5200 2 VLAGVFAGKK‐NH2 14749
Y Tyr 5375 3 Ac‐VLAGVFAGKK‐NH2 15793
W Trp 29050 4 Ac‐KKVLAGVFAG‐NH2 15651
M Met 980 5 Ac‐KVLASKKVFAG‐NH2 15685
R Arg 102 6 Ac‐KVFAGVFAGK‐NH2 20827
N Asn  136 7 Ac‐VFAGKKVLAS‐NH2 15685
Q Gln  142 8 Ac‐VFASKVLASK‐NH2 15698





































































































 MSD1 TIC, MS File (AM052711\002-0301.D)    API-ES, Pos, Scan, Frag: 150, "ESI pos scan"






























25.6  MSD1 TIC, MS File (AM052711\006-0701.D)    API-ES, Pos, Scan, Frag: 150, "ESI pos scan"








 MSD1 TIC, MS File (AM052711\008-0901.D)    API-ES, Pos, Scan, Frag: 150, "ESI pos scan"
Pep9 
25.6 

































*MSD1 SPC, time=4.542:4.769 of AM072711\001-0101.D    API-ES, Pos, Scan, Frag: 80, "ESI pos scan"
Max: 1.21214e+006




































































TIC  Peptide 1  Peptide 2  Peptide 3  Peptide 4  Peptide 5  Peptide 6  Peptide 7  Peptide 8  Peptide 9 
replicate 1  5.07E+07  8.49E+07 7.44E+07  4.75E+07  4.90E+07  3.97E+07  3.38E+07  5.00E+07  4.95E+07 
replicate 2  4.96E+07  8.32E+07 8.04E+07  4.63E+07  4.93E+07  3.99E+07  3.34E+07  4.79E+07  4.91E+07 
replicate 3  4.99E+07  8.59E+07 7.50E+07  4.62E+07  5.04E+07  3.98E+07  3.89E+07  4.75E+07  4.96E+07 
avg.  5.01E+07  8.47E+07  7.66E+07  4.67E+07  4.96E+07  3.98E+07  3.54E+07  4.84E+07  4.94E+07 
stdev.  597405  1341598  3332831  720513  781877  111637  3045113  1318999  278702 
% RSD  1.19  1.58  4.35  1.54  1.58  0.28  8.61  2.72  0.56 
Ret. Time 


















































































































































Sample ppm Na % Na ppm K % K
Peptide 1 4489 0.45 322 0.032
Peptide 2 2230 0.22 135 0.013
Peptide 3 3854 0.39 175 0.017
Peptide 4 10012 1.00 245 0.025
Peptide 5 1717 0.17 205 0.021
Peptide 6 1445 0.14 145 0.014
Peptide 7 7988 0.80 751 0.075
Peptide 8 3570 0.36 425 0.042
Peptide 9 733 0.07 131 0.013



















































































































































































































































































































Peptide 1 ‐57.8 11.235 0 2.74
Peptide 2 ‐77.0 11.933 0 5.00
Peptide 3 ‐73.2 11.584 0 2.36
Peptide 4 ‐60.3 14.860 2 1.25
Peptide 5 ‐60.6 11.365 1 1.68
Peptide 6 ‐70.1 17.352 1 1.46
Peptide 7 ‐70.1 12.031 0 1.97
Peptide 8 ‐86.7 10.763 1 1.67




































































% Intensity Final - Shots 500 - ADM May 23 2011 Pep1 CHCA  

























































Peptide 1 MH+ MNa+ MK+ total signal
average 2.74 1.41 2.09 2.08
standard deviation 0.15 0.09 0.23 0.13
%CV 5.40 6.04 10.92 6.22
confidence interval 0.04 0.03 0.07 0.04
Peptide 2
average 5.00 3.97 3.66 4.31
standard deviation 0.34 0.20 0.22 0.20
%CV 6.85 5.13 5.96 4.73
confidence interval 0.14 0.09 0.09 0.09
Peptide 3
average 2.36 2.21 2.03 2.23
standard deviation 0.08 0.18 0.12 0.09
%CV 3.43 8.34 6.05 3.86
confidence interval 0.03 0.08 0.05 0.04
Peptide 4
average 1.25 1.75 1.58 1.53
standard deviation 0.04 0.22 0.07 0.07
%CV 3.55 12.28 4.36 4.61
confidence interval 0.02 0.09 0.03 0.03
Peptide 5
average 1.68 2.37 2.40 2.08
standard deviation 0.05 0.09 0.16 0.04
%CV 3.19 3.81 6.48 2.14
confidence interval 0.02 0.04 0.06 0.02
Peptide 6
average 1.46 1.64 1.75 1.58
standard deviation 0.03 0.05 0.09 0.03
%CV 2.11 3.13 5.29 2.07
confidence interval 0.01 0.02 0.04 0.01
Peptide 7
average 1.97 2.18 2.20 2.12
standard deviation 0.11 0.08 0.21 0.06
%CV 5.42 3.66 9.67 2.90
confidence interval 0.04 0.03 0.09 0.02
Peptide 8
average 1.67 1.76 1.70 1.72
standard deviation 0.10 0.08 0.13 0.07
%CV 5.72 4.73 7.53 3.94





























Pep1    VLAGVFAGKK 
Pep2    VLAGVFAGKK-NH2 
Pep3    Ac-VLAGVFAGKK-NH2 
Pep4    Ac-KKVLAGVFAG-NH2 
Pep5    Ac-KVLASKVFAG-NH2 
Pep6    Ac-KVFAGVFAGK-NH2 
Pep7    Ac-VFAGKKVLAS-NH2 














































































































































































































































































































































































































  M e M
− −+ ⎯⎯→     (5‐5) 
 
In the final step,  ( )M H −− is formed from the intermediate M −   when hydrogen 
abstracted by a neutral matrix molecule (Equation 5‐6) 
   




















  ( ) ( )M H A M A H+ +⎯⎯→+ + + +←⎯   (5‐7) 
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FibA  ADSGEGDFLAEGGGVR   1535.6852  3.6  ‐3  < 975  Acidic 
AngI  DRVYIHPFHL  1295.6774  7.9  0.2  < 1000  Neutral 


























CHCA  189.0426  2.38 e‐7  2.5  809  acidic 
2,5‐dihydroxybenzoic acid  DHB  154.0266  2.38 e‐7  3.0  822  acidic 
6‐aza‐2‐thiothiamine  ATT  143.0153  1.42 e‐5  6.41  835  neutral
Norharmane  NORH  168.0687  5.60 e‐6  7.9  942  basic 
1,5‐Diaminonaphthalene  DAN  158.0844  5.09 e‐6  4.53  920  basic 
2‐amino‐5‐nitro‐4‐picoline*  ANP  153.0538  3.99 e‐5*  3.44  > 850  basic 
4‐nitroaniline*  4‐NA  138.0429  1.40 e‐4*  1.14  834  neutral


















































       
 DFT G3MP2 
 PA GA GB(anion) PA GA GB(anion) 
NOR 990 957 1448 976 996 1389 
ATT 928 897 1377 951 918 1361 
DHB 855 824 1392 848 869 1340 
CHCA 855 826 1403 813 795 1351 
       






































































































Figure 5-7.  Schematic of the flight path and ion optics of the AB 4700 MALDI 
TOF/TOF.   The experiments in the project used the Reflector mode and Reflector 












Table 5-4.  Parameter settings on the AB 4700 MALDI TOF/TOF.  
 
Mode Reflector Positive MS Reflector Negative MS 




1060, 1296 or 1536  1058, 1294 or 1534 
Laser shots/ 
spectrum 




2200 – 2800  2200 – 2800  
Source 1 20 kV -20 kV 
Grid 1 14.257 kV -14.257 kV 
Y1 Deflector -0.2 - 0.2 
X1 Deflector 0.08 -0.08 
Y2 Deflector 0.08 -0.08 
X2 Deflector 0.00 0.00 
Lens 1 7.5 kV -7.5 kV 
Lens 2 6.0 kV -6.0 kV 
Mirror 1 14.029 - 14.029 
Mirror 2 20.198 - 20.198 
Reflector Detector -2.1  -2.1  
X3 Deflector 0.000 0.000 



















































































































































































<<058_MS>> 4700 Reflector Spec #1 MC[BP = 1294.3, 27565]


































































4700 Reflector Spec #1 MC[BP = 1316.3, 7575]
 






































(M-H)- (M-H-NH3)- (M-H-NH3+Na)- 


























































































































































































































































IS2 = 84.5% IS1
Refl2 = 52.4% Refl1































AB 4700 yes ESD 0.9 0.4 
Bruker Autoflex 
III no ESD 1.3 0.3 
Bruker Autoflex 
III yes ESD 1.8 0.5 
Bruker Autoflex 
III no dried drop 4.3 0.4 
Bruker Autoflex 




















































































































































































































950 1010 1070 1130 1190 1250
4.3E+4
4.3E+4











































































































































                          1060.4 































































































4700 Reflector Spec #1 MC[BP = 1060.6, 25688]


















































































ATT adducts impurity 
          1060.4

























































































RPPGFSPFR (M + H)+
          1060.4
(M  - H)-








950 1010 1070 1130 1190 1250
1.6E+4
1.6E+4


















































































<<112_MS>> 4700 Reflector Spec #1 MC[BP = 1060.5, 3047]
RPPGFSPFR 
          1060.4








































































































































































































































































































































































































































































































































































































































































































































                                1296.8 
(M-2H+Na)- 
(M-H)- B 







799.0 1040.8 1282.6 1524.4 1766.2 2008.0
1.4E+4
1.4E+4


























































































































































































































































































































































































































































































































































































































































































































































































































           1534.5























































































































                  1536.5 











1504.0 1523.2 1542.4 1561.6 1580.8 1600.0
4500
4500



























<<086_MS>> 4700 Reflector Spec #1 MC=>AdvBC(32,0.5,0.1)[BP = 1534.3, 4217]
























































4700 Reflector Spec #1 MC[BP = 1536.5, 1802]










































































Figure 5-30:  P/N results for FibA in each of the five matrices. The solid line indicates a 




























































































Table 5-6:  Summary of the average positive-to-negative (P/N) ion ratio and the uncertainty (expressed as the standard 
deviation, with N = 6) for each peptide - matrix combination.   
 
 CHCA  DHB  ATT  NOR  
  P/N Std Dev. P/N Std Dev. P/N Std Dev. P/N Std Dev. 
Bradykinin 10.8 0.77 3.2 0.54 2.6 0.58 0.54 0.13 
Angiotensin I 6.7 0.85 2.4 0.47 1.9 0.3 0.31 0.04 


















Figure 5-31:  A plot of the Pos/Neg ratios listed in Table 5-6.  The matrices are placed in order of increasing proton affinity 










































































































































1536.6 1060.5 1296.6 























































































































































































































































































































































































































































































































































































































































































































APPENDIX A: LIST OF ABBREVIATIONS 
 
 
AngI  angiotensin I 
AngII  angiotensin II 
AngIII angiotensin III 
A   analyte 
ACN  acetonitrile 
ATT  6‐aza‐2‐thiothymine  
CsI    cesium iodide 
CHCA  α-cyano-4-hydroxycinnamic acid  
CRM  Charge residue model 
CV    coefficient of variation 
CI   confidence interval 
d    distance 
Da    Daltons 
DAN  1,5-diaminonaphthalene 
DC   direct current 
DF    degrees of freedom 
DHB    2,5-dihydroxybenzoic acid  
DI  H2O   deionized water 
ESD    electrospray deposition 
ESI -MS electrospray ionization mass spectrometry 
HPLC   high pressure liquid chromatography 
FibA  fibrinopeptide A 
i.d.    inner diameter 
IEM   Ion evaporation model  
IPA    isopropyl alcohol 
IS    internal standard 
K+   potassium cation 
KE    kinetic energy 
kV  kilovolt 
L    length of flight tube 
LDI    laser desorption/ionization 
M   matrix 
m    mass 
M/A    matrix to analyte mole ratio 
m/z    mass to charge ratio 
MALDI   matrix assisted laser desorption ionization 
MCP    microchannel plate 
MeOH  methanol 
MS    mass spectrometry 
MSI   mass spectrometry imaging 
MW    molecular weight 
314 
 
Na+   sodium cation 
Nd:YAG  neodymium-doped yttrium aluminium garnet 
NORH norharmane 
pmol  picomole 
o.d.   outside diameter 
OCN    oscillating capillary nebulizer 
R2    coefficient of determination 
RS  renin substrate 
RSD   relative standard deviation 
S/N   signal to noise ratio 
SS    stainless steel 
TOF    time-of-flight  
uL  microliter 
UV/Vis   ultraviolet/ visible 



























































































































Figure B-1:  ESI mass spectrum of the M/A = 500 sample 
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Figure B-2:  ESI mass spectrum of the M/A = 750 sample 
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Figure B-3:  ESI mass spectrum of the M/A = 1000 sample 
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Figure B-4:  ESI mass spectrum of the M/A = 1500 sample 
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